Skip to content

    Recently Viewed


      Lisa Ling

      Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.

      Cato T. Laurencin, M.D., Ph.D.

      Dr. Laurencin is University Professor at the University of Connecticut and Chief Executive Officer of the Connecticut Convergence Institute at the University of Connecticut. He is an expert in health disparities and is the Editor-in-Chief of the Journal of Racial and Ethnic Health Disparities, as well as a Core Faculty Member of the Africana Studies Institute at the University of Connecticut.

      Mathai Mammen, M.D., Ph.D.

      Dr. Mammen is Global Head of Janssen Research & Development, Johnson & Johnson. Previously, he was Senior Vice President at Merck Research Laboratories. He received his M.D. from Harvard Medical School/Massachusetts Institute of Technology (HST program) and his Ph.D. in Chemistry from Harvard University.

      Paul Stoffels, M.D.

      Dr. Stoffels is the Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. He spearheads the research and product pipeline by leading teams across all of the company’s sectors to set the company-wide innovation agenda, discovering and developing transformational healthcare solutions.

      Husseini K. Manji, M.D., FRCPC

      Johnson & Johnson’s Dr. Husseini K. Manji oversees all neuroscience programs investigating treatments for mood disorders, schizophrenia, and neurodegenerative diseases, such as Alzheimer’s disease. Previously, Dr. Manji was Chief of the Laboratory of Molecular Pathophysiology & Experimental Therapeutics at the National Institutes of Health (NIH).
      RTAV Vikram Patel, MBBS, Ph.D.

      Vikram Patel, MBBS, Ph.D.

      Dr. Patel is The Pershing Square Professor of Global Health at the Harvard Medical School. His work has focused on the burden of mental health problems, their association with social disadvantage and the use of community resources for their prevention and treatment in low-resource settings.

      The 5 stages of COVID-19 vaccine development: What you need to know about how a clinical trial works

      Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.